COMMUNIQUÉS West-GlobeNewswire

ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 22:05

BOSTON, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 36 th Annual J.P. Morgan Healthcare [...]

GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Conference

21/12/2017 - 22:03

CARLSBAD, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief [...]

Altimmune to Participate in the 10th Annual Biotech Showcase in San Francisco, January 8 – 10, 2018

21/12/2017 - 22:01

GAITHERSBURG, Md., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]

Antares Pharma Provides XYOSTED™ Regulatory Update

21/12/2017 - 22:01

EWING, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that a written request for a Type A meeting, along with a comprehensive briefing document, have been submitted to the U [...]

ProPhase Labs, Inc. Announces Final Results of Its Tender Offer

21/12/2017 - 22:00

DOYLESTOWN, Pa., Dec. 21, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (“ProPhase”), announced today the final results of [...]

BriaCell Announces Closing of Warrant Incentive Program

21/12/2017 - 20:58

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRE SERVICES BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the " Company [...]

Burcon Announces Appointment of David Ju to Its Board of Directors

21/12/2017 - 19:53

VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”) is pleased to announce the appointment of Mr. David Ju as an [...]

Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum

21/12/2017 - 19:22

SEATTLE, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Arzeda , The Protein Design Company TM , today announced that biotechnology veteran William “Bill” Baum has joined the company’s board of directors. Baum is a highly respected [...]

Yield10 Bioscience Announces Closing of $14.5 Million Public Offering

21/12/2017 - 19:00

WOBURN, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the closing of an underwritten public offering of units for gross proceeds of $14.5 million, which includes the [...]

Sensorion Successfully Closes on a €1.6 Million Euro Placement with Cochlear

21/12/2017 - 18:30

MONTPELLIER, France, Dec. 21, 2017 (GLOBE NEWSWIRE) -- (FR0012596468 — ALSEN) — Sensorion, a biotech specializing in the treatment of inner ear diseases (the "Company"), announces that it has today carried out a capital [...]

Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants

21/12/2017 - 18:28

VICTORIA, B.C., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSX-V: EMH ) (OTCQX:EMHTF) has elected to exercise its right to accelerate the exercise of $2.00 common [...]

Crown Bioscience Announces Merger with JSR Corporation

21/12/2017 - 17:39

SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing [...]

One-Year Follow-Up Shows 71.4% Progression-Free Survival in 14 Prostate Cancer Patients Treated with ProscaVax in Phase 1 Clinical Trial

21/12/2017 - 17:26

BATON ROUGE, La., Dec. 21, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of a proprietary [...]

ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock

21/12/2017 - 17:00

PORTLAND, Maine, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (“ImmuCell” or the “Company”) (Nasdaq: ICCC ), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]

Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLetTM

21/12/2017 - 15:47

Company announcement - No. 56/2017 Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLet TM Zealand Pharma makes an initial USD 1.5 million equity investment in the [...]

The Financial Calendar of JSC “Grindeks” for the year of 2018

21/12/2017 - 15:22

JSC "Grindeks" plans to publish its: non-audited interim financial statement for the 12-month period of 2017 on 28 February 2018; non-audited interim financial statement for the 3-month period of 2018 on 31 May 2018; [...]

HMS Teams with Halfpenny Technologies to Strengthen Payer-Provider Collaboration, Promoting Seamless Care Management

21/12/2017 - 15:11

IRVING, Texas, Dec. 21, 2017 (GLOBE NEWSWIRE) -- HMS , a leading provider of cost containment and health management solutions to the U.S. healthcare market, today announced the launch of a strategic partnership with [...]

NSS Labs Announces Industry’s First Data Center Security Gateway Group Test Results

21/12/2017 - 15:00

Five Products Receive Recommended Rating for IPv4; Four Products Receive Recommended Rating for IPv6 AUSTIN, Texas, Dec. 21, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, [...]

NewLink Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 15:00

AMES, Iowa, Dec. 21, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today that the company will present at the 36 th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, [...]